The Cancer Research Committee of the American Society of Clinical Oncology (ASCO) recently released a draft of a white paper entitled “Defining clinically meaningful outcomes: ASCO recommendations to raise the bar for clinical trials”. Lee M. Ellis, M.D., immediate past Chair of the Committee and lead author of the draft guidelines, talked to Man Tsuey Tse about the aims and their potential impact on the development of anticancer therapeutics.
Enjoying our latest content?
Log in or create an account to continue
- Access the most recent journalism from Nature's award-winning team
- Explore the latest features & opinion covering groundbreaking research
or
Rights and permissions
About this article
Cite this article
Lee M. Ellis. Nat Rev Drug Discov 12, 572–573 (2013). https://doi.org/10.1038/nrd4085
Published:
Issue date:
DOI: https://doi.org/10.1038/nrd4085
